Beryl Capital Management LLC 13D and 13G filings for Zynerba Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-08 7:22 pm Sale | 2023-12-31 | 13G | Zynerba Pharmaceuticals, Inc. ZYNE | Beryl Capital Management LLC | 0 0.000% | -4,426,381 (Position Closed) | Filing |
| 2023-09-05 4:39 pm Purchase | 2023-08-24 | 13G | Zynerba Pharmaceuticals, Inc. ZYNE | Beryl Capital Management LLC | 4,426,381 8.200% | 4,426,381 (New Position) | Filing |